These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29129706)
1. Design, synthesis, and biological evaluation of novel 7-deazapurine nucleoside derivatives as potential anti-dengue virus agents. Lin C; Yu J; Hussain M; Zhou Y; Duan A; Pan W; Yuan J; Zhang J Antiviral Res; 2018 Jan; 149():95-105. PubMed ID: 29129706 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase. Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011 [TBL] [Abstract][Full Text] [Related]
3. Narasin, a novel antiviral compound that blocks dengue virus protein expression. Low JS; Wu KX; Chen KC; Ng MM; Chu JJ Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902 [TBL] [Abstract][Full Text] [Related]
4. Discovery and optimization of phthalazinone derivatives as a new class of potent dengue virus inhibitors. Lu D; Liu J; Zhang Y; Liu F; Zeng L; Peng R; Yang L; Ying H; Tang W; Chen W; Zuo J; Tong X; Liu T; Hu Y Eur J Med Chem; 2018 Feb; 145():328-337. PubMed ID: 29335200 [TBL] [Abstract][Full Text] [Related]
5. Discovery of Indole Derivatives as Novel and Potent Dengue Virus Inhibitors. Bardiot D; Koukni M; Smets W; Carlens G; McNaughton M; Kaptein S; Dallmeier K; Chaltin P; Neyts J; Marchand A J Med Chem; 2018 Sep; 61(18):8390-8401. PubMed ID: 30149709 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel diarylpyrazolylquinoline derivatives as potent anti-dengue virus agents. Lee JC; Tseng CK; Lin CK; Tseng CH Eur J Med Chem; 2017 Dec; 141():282-292. PubMed ID: 29031073 [TBL] [Abstract][Full Text] [Related]
8. Identification of Compound-B, a novel anti-dengue virus agent targeting the non-structural protein 4A. Nobori H; Toba S; Yoshida R; Hall WW; Orba Y; Sawa H; Sato A Antiviral Res; 2018 Jul; 155():60-66. PubMed ID: 29758236 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, antiproliferative and anti-dengue virus evaluations of 2-aroyl-3-arylquinoline derivatives. Tseng CH; Lin CK; Chen YL; Hsu CY; Wu HN; Tseng CK; Lee JC Eur J Med Chem; 2014 May; 79():66-76. PubMed ID: 24727241 [TBL] [Abstract][Full Text] [Related]
10. Drug repurposing of quinine as antiviral against dengue virus infection. Malakar S; Sreelatha L; Dechtawewat T; Noisakran S; Yenchitsomanus PT; Chu JJH; Limjindaporn T Virus Res; 2018 Aug; 255():171-178. PubMed ID: 30055216 [TBL] [Abstract][Full Text] [Related]
12. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143 [TBL] [Abstract][Full Text] [Related]
13. Discovery of 3-Arylquinoxaline Derivatives as Potential Anti-Dengue Virus Agents. Tseng CH; Han CR; Tang KW Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561542 [TBL] [Abstract][Full Text] [Related]
14. The search for nucleoside/nucleotide analog inhibitors of dengue virus. Chen YL; Yokokawa F; Shi PY Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of cytisine derivatives against dengue virus types 1 and 2. Tsypysheva IP; Lai HC; Kiu YT; Koval'skaya AV; Tsypyshev DO; Huang SH; Lin CW Bioorg Med Chem Lett; 2021 Dec; 54():128437. PubMed ID: 34737087 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel imidazole nucleosides as potential anti-dengue virus agents. Okano Y; Saito-Tarashima N; Kurosawa M; Iwabu A; Ota M; Watanabe T; Kato F; Hishiki T; Fujimuro M; Minakawa N Bioorg Med Chem; 2019 Jun; 27(11):2181-2186. PubMed ID: 31003866 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of ST081006 against the dengue virus. Lee JK; Chui JLM; Lee RCH; Kong HY; Chin WX; Chu JJH Antiviral Res; 2019 Nov; 171():104589. PubMed ID: 31421165 [TBL] [Abstract][Full Text] [Related]
19. Anti-dengue-virus activity and structure-activity relationship studies of lycorine derivatives. Wang P; Li LF; Wang QY; Shang LQ; Shi PY; Yin Z ChemMedChem; 2014 Jul; 9(7):1522-33. PubMed ID: 24574246 [TBL] [Abstract][Full Text] [Related]
20. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. Chew MF; Tham HW; Rajik M; Sharifah SH J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]